Hanyu Haruo, Hirao Kentaro, Shimizu Soichiro, Iwamoto Toshihiko, Koizumi Kiyoshi, Abe Kimihiko
Department of Geriatric Medicine, Tokyo Medical University, Japan.
Nucl Med Commun. 2007 Apr;28(4):281-7. doi: 10.1097/MNM.0b013e32804c58aa.
We compared the effects of nilvadipine and amlodipine on the cognitive function and regional cerebral blood flow (rCBF) in patients with mild cognitive impairment (MCI) and hypertension.
Twelve patients with MCI and hypertension were randomly assigned to receive nilvadipine or amlodipine for 12-16 weeks. Before and after treatment all patients underwent neuropsychological evaluation and single photon emission computed tomography (SPECT) studies with N-isopropyl-p-[123I]iodoamphetamine.
Both nilvadipine (n=6) and amlodipine (n=6) groups had similar significant reduction in systolic and diastolic blood pressure after treatment. The Logical Memory subscore of the Wechsler Memory Scale-Revised increased significantly in the nilvadipine group, but not in the amlodipine group after treatment. Although SPECT demonstrated no significant differences in rCBF deficits at baseline between the two groups, the nilvadipine group showed an improvement of rCBF in the left frontal lobe, while the amlodipine group showed a decrease of rCBF in the left temporal lobe.
Our results suggest that nilvadipine, a highly lipophilic agent that easily penetrates the central nervous system, may have additional benefits and be potentially useful for the treatment of patients with MCI and hypertension.
我们比较了尼伐地平与氨氯地平对轻度认知障碍(MCI)合并高血压患者认知功能和局部脑血流量(rCBF)的影响。
12例MCI合并高血压患者被随机分配接受尼伐地平或氨氯地平治疗12 - 16周。治疗前后,所有患者均接受神经心理学评估以及使用N - 异丙基 - p - [123I]碘安非他明的单光子发射计算机断层扫描(SPECT)研究。
治疗后,尼伐地平组(n = 6)和氨氯地平组(n = 6)的收缩压和舒张压均有相似的显著降低。治疗后,韦氏记忆量表修订版的逻辑记忆子评分在尼伐地平组显著升高,而在氨氯地平组未升高。尽管SPECT显示两组基线时rCBF缺陷无显著差异,但尼伐地平组左额叶rCBF有所改善,而氨氯地平组左颞叶rCBF有所下降。
我们的结果表明,尼伐地平作为一种极易穿透中枢神经系统的高亲脂性药物,可能具有额外益处,对治疗MCI合并高血压患者可能有用。